Denosumab and Risk of Community-acquired Pneumonia: A Population-based Cohort Study.
Houchen LyuSizheng ZhaoJiatian LiXiaoxiao LiYilun WangDongxing XieChao ZengGuang-Hua LeiYuqing ZhangHui LiPublished in: The Journal of clinical endocrinology and metabolism (2022)
Denosumab does not significantly increase the susceptibility of community-acquired pneumonia and could possibly be safely used for the management of osteoporosis.